ArticleBMC cancer2023

Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide.

Takashi Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.